2022 Diabetic Lower Extremity Symposium
An In-Person Conference | November 3-4, 2022
Joseph B. Martin Conference Center, Boston, MA
The Rongxiang Xu, MD, Center for Regenerative Therapeutics at Beth Israel Deaconess Medical Center and the Wyss Institute at Harvard University present:
The Diabetic Lower Extremity Symposium
From Innovation to Therapy
Joseph B. Martin Conference Center, Boston, MA November 3-4, 2022
This CME meeting will focus on the management of diabetic lower extremity and other chronic wounds. The meeting will include top experts from all over the world and will facilitate interaction between small and big pharma and academicians.
What is this meeting about?
Diabetic foot problems significantly impair the quality of life of diabetic patients. Each year in the United States, these complications lead to more than 750,000 new diabetic foot ulcers and 70,000 lower extremity amputations. This extraordinary three day symposium will promote better understanding of the unmet management needs of Diabetic Lower Extremity (DLE) complications and the new therapeutic approaches that are currently under development.
* Our 2017 accreditation is displayed for reference. Please check back for updates!
In support of improving patient care, this activity has been planned and implemented by Amedco LLC and Well Assembled Meetings. Amedco LLC is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Physicians (ACCME) Credit Designation
Amedco LLC designates this live activity for a maximum of 9.75 AMA PRA Category 1 CreditsTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Who should attend this symposium?
Call for Abstracts
The symposium organizers welcome abstracts for poster submissions from academic labs, clinical units and all levels of industry. Posters that address the biology, management and treatment of diabetic lower extremity complications, including new potential therapeutic strategies will be considered. The best three posters will be presented as oral presentations. Prizes for the best posters will be offered.